A peer reviewer questioned the premise of our study into the potential impact of abruptly ending PEPFAR funding. Then it ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Protests are therefore at their most useful when they’re about something that’s being done half by accident or out of ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Pepfar, a global initiative to fight HIV/Aids, has saved millions of lives since its launch in 2003. Now its future is ...

After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding. But some experts argue that US health initiatives had more bang for buck ...

Activists expressed disappointment that Finance Minister Enoch Godongwana failed to account for the additional finances ...

After Trump’s order prompted a public outcry over the halting of such humanitarian programs, Rubio issued two waivers ...

As a medical missionary, I use PEPFAR-funded meds to save unborn babies, new mothers, and fellow church members from needless ...

The recent termination of USAid to HIV/Aids and TB organisations in South Africa was a bone of contention in the 2025 budget ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

The withdrawal of Pepfar funding has left organisations grappling with devastating consequences, as two key players share ...